Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases

Related Experiment Video

Updated: Dec 29, 2025

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

14.0K

Kang Chen1, Yuting Huang2, Radhika Singh3

  • 1Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Journal of Cellular Physiology
|January 30, 2020
PubMed

Insights

Stem cell therapy shows promise for heart repair, but potential risks like cardiac arrhythmia require careful consideration of cell sources and electrical function. Further research is essential for safe cardiac regeneration.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Biomedical Engineering

Background:

  • Ischemic heart disease and congestive heart failure cause significant mortality.
  • Myocardial infarction affects 1.5 million Americans annually.
  • Current treatments cannot repair damaged cardiomyocytes.

Purpose of the Study:

  • To review stem cell sources for cardiac regeneration.
  • To discuss the arrhythmogenic risks associated with stem cell therapy.
  • To address safety concerns in stem cell-based cardiac repair.

Main Methods:

  • Literature review of stem cell sources for cardiac regeneration.
  • Analysis of safety data from clinical trials.
  • Evaluation of electrical properties of stem cell-derived cardiomyocytes.

Main Results:

  • Stem cell therapy is a promising approach for generating new cardiomyocytes.
  • Concerns exist regarding electrical dysfunctions and cardiac arrhythmia post-therapy.
  • Different cell sources may pose varying arrhythmogenic risks.

Conclusions:

  • Stem cell therapy offers potential for heart regeneration.
  • Careful selection of cell sources is crucial to mitigate arrhythmogenic risks.
  • Further research is needed to ensure the safety and efficacy of stem cell therapy for heart disease.

Keywords:
arrhythmogenic riskcardiovascular diseasesstem cell

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.7K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K